Advertisement

The Scientist

» drug development and neuroscience

Most Recent

image: Pioneering Neurologist Dies

Pioneering Neurologist Dies

By | August 27, 2013

Neuroscientist and pediatric neurologist Peter Huttenlocher, who discovered that synapse growth peaks in early childhood, has passed away at age 82.

0 Comments

image: Brain-Based Labels Bunk?

Brain-Based Labels Bunk?

By | August 19, 2013

An fMRI study shows speculations that people are “left-brained” versus “right-brained” are not backed by evidence.

2 Comments

image: Opinion: Sexual Dysfunction Matters

Opinion: Sexual Dysfunction Matters

By | August 19, 2013

Desire and arousal disorders require the biopharmaceutical industry’s attention.

7 Comments

image: Week in Review: August 5–9

Week in Review: August 5–9

By | August 9, 2013

Flu researchers propose H7N9 studies; NIH makes deal to share HeLa genome; herbal “remedies” can cause cancer; scientists record grid cell activity in humans

0 Comments

image: Mapping Humans’ Mental GPS

Mapping Humans’ Mental GPS

By | August 5, 2013

Scientists have located a type of brain cell that helps people navigate unfamiliar territory.

1 Comment

image: Remodeling Myelin

Remodeling Myelin

By | August 1, 2013

New oligodendrocytes in the adult mouse brain appear to remodel existing myelin sheaths, which may fine-tune the speed of nerve impulses.

0 Comments

image: Week in Review, July 15–19

Week in Review, July 15–19

By | July 19, 2013

Bias in preclinical research; medical marijuana for kids; a swath of microbial genomes; plastic ocean habitats; rethinking scientific evaluation

0 Comments

image: Cancer Gene Data Released

Cancer Gene Data Released

By | July 18, 2013

NCI has made public the largest-ever database of cancer-specific gene variations, paving the way for the development of new drugs and therapies.

0 Comments

image: Medical Marijuana for Kids?

Medical Marijuana for Kids?

By | July 17, 2013

The drug has brought relief to children suffering from cancer and other serious ailments, but getting access is often limited by considerable regulatory hurdles.

7 Comments

image: Misconduct Delayed Drug Approval

Misconduct Delayed Drug Approval

By | July 10, 2013

FDA endorsement of a new blood-thinning drug was held back for almost a year because the agency discovered misconduct at clinical trial sites in China.  

2 Comments

Advertisement

Popular Now

  1. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  2. Most Earth-like Planet Found
  3. Ancient Viruses as Gene Therapy Vectors
  4. Judge Decides on GM Rice Retraction
Advertisement
PDA
PDA
Advertisement